Hite Bio: Two drugs are planned to be selected for national centralized drug procurement. Hite Bio announced that the company participated in the tenth batch of national centralized drug procurement. According to the selected results released by the joint procurement, roxatidine acetate hydrochloride and pentoxifylline injection for injection of the company are selected for this centralized procurement. These two drugs are suitable for the treatment of upper gastrointestinal bleeding and peripheral arterial diseases respectively. The procurement cycle is from the date of implementation of the selected results to December 31, 2027, during which medical institutions will give priority to the use of selected drugs. The company obtained the Drug Registration Certificate of the above drugs in 2024, but it has not generated sales revenue this year. This election will help to enhance the brand influence of the company and have a positive impact on the company's development.Zhu Haoxiang, the Chinese director of the US SEC, resigned. The US Securities and Exchange Commission recently announced that Zhu Haoxiang, the director of the Trading and Marketing Department, will leave on December 10, 2024, and he will return to the Si Long School of Management at MIT to continue to serve as an associate professor of finance. As one of the important members of Gary Gensler, the current chairman of the SEC, Zhu Haoxiang was appointed by the SEC in December 2021. (Caixin. com)Zhendong Pharmaceutical has set up a new health management service company. The enterprise search APP shows that recently, Shanxi Zhendong Health Management Service Co., Ltd. was established, with Zhao Jin as the legal representative and a registered capital of 10 million yuan. Its business scope includes: remote health management services; Health consulting services (excluding medical services), etc. Enterprise investigation shows that the company is wholly owned by Zhendong Pharmaceutical.
CEO of Cloud Whale Intelligence responded to layoffs: In order to optimize the organizational structure, it was streamlined from 1,600 to 1,400. Zhang Junbin, CEO of Cloud Whale Intelligence, recently issued a statement in a circle of friends, responding to previous reports of layoffs: "The company's personnel adjustment is to optimize the organizational structure and improve organizational efficiency." According to Zhang Junbin, the company was downsized from the original 1,600 to 1,400, which was not a large-scale layoff. Previously, a number of insiders and employees of Cloud Whale Intelligence revealed to Sina Technology that the company has recently started a major layoff. This round of layoffs involves a wide range of business departments, including development departments, testing departments, etc., and in groups, some groups directly cut their staff by half, and extreme groups cut their staff by 65%. In addition, the company's 12 director-level leaders, three of whom left in the past year, "is very mobile." (Sina Technology)Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.The yield of China's 30-year national debt "24 Special National Debt 06" fell below 2%, hitting a new low.
Yu Chengdong Tik Tok rose more than 400,000 yuan overnight. On the evening of 12th, Yu Chengdong registered Tik Tok account, and the authentication information was displayed as "Managing Director of Huawei, Chairman of BG& BU, a terminal smart car solution". As of the 13th, the powder rose by over 400,000 overnight. (Oriental Finance)Goldman Sachs lowered the UK's GDP growth forecast for 2024 from the previous 1.2% to 1.0%.On the 13th, glass fell by 2.14%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract glass closed at 2505, up or down by -2.14%, with a turnover of 671,300 lots. The position data showed that the top 20 seats were clear, and the difference position was 46,081 lots. The total turnover of glass futures contracts was 999,900 lots, an increase of 189,100 lots over the previous day. The first 20 seats in the contract held 565,600 lots, a decrease of 12,000 lots from the previous day. The short positions in the top 20 seats of the contract were 661,500 lots, a decrease of 13,600 lots from the previous day. (Sina Futures)
Strategy guide
12-14
Strategy guide
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide 12-14